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Background: Many biomedical applications require the expression or production of therapeutic hetero-multimeric
proteins/protein complexes: in most cases only accomplished by co-ordinated co-expression within the same cell.
Foot-and-mouth disease virus 2A (F2A) and ‘2A-like’ sequences are now widely used for this purpose. Since 2A
mediates a co-translational ‘cleavage’ at its own C-terminus, sequences encoding multiple proteins (linked via 2As)
can be concatenated into a single ORF: a single transgene. It has been shown that in some cases, however, the
cleavage efficiency of shorter versions of F2A may be inhibited by the C-terminus of certain gene sequences
immediately upstream of F2A. This paper describes further work to optimise F2A for co-expression strategies.
Results: We have inserted F2A of various lengths in between GFP and CherryFP ‘reporter’ proteins (in reciprocal or
tandem arrangements). The co-expression of these proteins and cleavage efficiencies of F2As of various lengths
were studied by in vitro coupled transcription and translation in rabbit reticulocyte lysates, western blotting of HeLa
cell lysates and fluorescence microscopy.
Conclusions: Optimal and suboptimal lengths of F2A sequences were identified as a result of detailed ‘fine-tuning’
of the F2A sequence. Based on our data and the model according to which 2A activity is a product of its
interaction with the exit tunnel of the ribosome, we suggest the length of the F2A sequence which is not ‘sensitive’
to the C-terminus of the upstream protein that can be successfully used for co-expression of two proteins for
biomedical applications.
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Many biomedical applications rely on the ability to co-
express multiple proteins within the same cell. These
may include co-expression of genes encoding subunits
of hetero-multimeric therapeutic proteins (e.g. im-
munoglobulins, cell receptors, interleukins, enzymes,
transcription factors), multiple therapeutic genes for a
combined and/or synergistic effects (e.g. immune-
stimulatory), and co-expression of therapeutic genes
plus required co-factor or marker gene (e.g. drug re-
sistance, colour, fluorescence) for detection or selec-
tion of transduced cells (reviewed by de Felipe [1] and
Pfutzner [2]).* Correspondence: minskayakat@hotmail.com
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reproduction in any medium, provided the orVarious conventional approaches for protein co-
expression have been utilized such as the use of multiple
internal promoters, internal ribosome entry sites (IRESes),
messenger RNA splicing, fusion proteins, and post-
translational proteolysis. There are, however, disadvan-
tages associated with each of these approaches. For ex-
ample, steric effects often lead to loss of function of fused
proteins. In order to avoid such problems, proteinase
cleavage sites can be incorporated. In this case both the
polyprotein substrate and the processing enzyme must,
however, be co-expressed in the same subcellular site.
When multiple promoters have been employed, interfer-
ence has occurred between promoters leading to promoter
suppression and rearrangement. IRES elements, identified
both in viral and cellular eukaryotic mRNAs, differ in
length (from 130 bp to 1 kb). The most efficient viral
IRESes successfully utilized in vectors used for biomedicall Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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problems in packaging within size-restricted vectors com-
monly used for biomedical applications such as adeno-
associated and retroviral vectors. Furthermore, expression
from IRESes is dependent on various cellular binding
factors which vary amongst different cell types. Critically,
the protein downstream of the IRES is only expressed
to ~10% of that upstream [1-7].
Picornavirus (foot-and-mouth disease virus; FMDV)
F2A and ‘2A-like’ sequences are now widely used for co-
expression of multiple genes. The 2A region of the FMDV
encodes a sequence that mediates self-processing by a
translational effect variously referred to as ‘ribosome skip-
ping’, ‘stop-go’ and ‘stop-carry on’ translation [8,9]. Analysis
of recombinant polyproteins and artificial polyprotein sys-
tems in which 2A was inserted between two reporter
proteins showed that the FMDV 2A oligopeptide (plus the
N-terminal proline of the 2B downstream protein) co-
translationally ‘self-cleaved’ at the glycyl-prolyl pair site
corresponding to the 2A/2B junction (−LLNFDLLKLA-
GDVESNPG↓P-). The use of longer versions of 2A with
N-terminal extensions derived from FMDV capsid protein
1D upstream of 2A (~30aa in total) was reported to pro-
duce higher levels of cleavage [10-13].
For simplicity, the co-translational ribosome skipping
event will be referred to as ‘cleavage’. The merits of this
system are: (i) co-expression of proteins linked by 2A is
independent of the cell type (since cleavage activity is
only dependent on eukaryotic ribosomes, structurally
highly conserved amongst the eukaryota), (ii) multiple
proteins are co-expressed in equimolar amounts from a
single transcript mRNA (single ORF) under the control
of only one promoter and, (iii) 2A is smaller (54-174 bp)
compared to IRES elements. This makes this unique se-
quence an attractive substitute for previously used ap-
proaches for co-expression of multiple genes [10,14-16].
However, it should be noted that (i) 2A remains as a C-
terminal extension of the upstream product, and (ii) pro-
line forms the N terminus of the downstream protein.
To date, various reporter proteins together with pro-
teins requiring discrete co- and post-translational sub-
cellular localization have been successfully co-expressed
in in vitro and in vivo heterologous systems using F2A
sequences of various lengths [11,17-24]. However, some
limitations of using this strategy were reported. Firstly,
whilst the longest F2A sequence (58aa) tested to date
was shown to produce the most efficient cleavage, the
C-terminal F2A extension of the upstream translation
product may have an effect on protein confirmation and
activity - such as in the production of monoclonal anti-
bodies or expression of enzymes. To minimise this ef-
fect, a number of laboratories have used shorter versions
of F2As [11,14,19,22,25], or, incorporated a furin cleav-
age site between the C-terminus of the upstream proteinand N-terminus of the 2A sequence such that the C-
terminal extension is ‘trimmed’ away. This approach can
only be used for secreted proteins, however, since furin
is primarily localised within the Golgi apparatus [22,26].
It has been reported, however, that the efficiency of
F2A cleavage may be greatly inhibited in certain cases
where the C-terminal sequences of the upstream gene
were shown to lower F2A activity [27,28]. It was pro-
posed that such inhibition could be overcome by the
use of different lengths of the sequence between the C-
terminal region and F2A [11]. To further investigate
F2A cleavage efficiency and to optimise the 2A system
for the coordinate expression of two genes from a
bicistronic vector, we generated constructs encoding
two fluorescent ‘reporter’ proteins, GFP and CherryFP,
in different positions linked by F2A sequences of vari-
ous lengths. The co-expression of these cytoplasmic
proteins and the comparative cleavage efficiencies were
determined both in vivo in HeLa cells, a human cell line
most commonly used in biomedical applications (west-
ern blotting/fluorescence microscopy), and in vitro
(coupled transcription/translation system).
Results
Co-expression of GFP and CherryFP fluorescent proteins
from pGFP-F2A-CherryFP constructs
A series of constructs were produced encoding GFP and
CherryFP fluorescent ‘reporter’ proteins under the control
of both CMV and T7 promoters. Sequences encoding
GFP and CherryFP were separated by either the longest
F2A sequence (F2A58) or N-terminally truncated versions
of various lengths (F2A50, F240, F2A30, F2A20, and F2A18;
Figure 1), to establish the optimal length of F2A sequence
for co-expression of two proteins and their relative clea-
vage efficiencies. The expected translation products were
cleaved [GFP-F2A] and CherryFP, and the uncleaved
polyprotein [GFP-F2A-CherryFP] (Figure 2a).
For the in vitro translation studies, rabbit reticulocyte
lysates were programmed with the pGFP-F2A-CherryFP
series of constructs and the translation products re-
solved by 12% SDS-PAGE (Figure 2b). As expected, two
major translation products (of the expected molecular
weights) were observed. In each track the upper slower
migrating product corresponded to either [GFP-F2A58]
(34.5 kDa), [GFP-F2A50] (33.5 kDa), [GFP-F2A40] (32.3 kDa)
or [GFP-F2A30] (31.2 kDa). The second product corres-
ponded to the CherryFP cleavage product. Translation
profiles derived from pGFP-F2A-CherryFP constructs
also showed a low level of internal initiation which pro-
duced products of lower molecular weights. The bands,
based on the gradual decrease in molecular weight,
were comparable to the [GFP-F2A] cleavage products
and correspond to products produced by leaky scan-
ning, initiating within GFP at Met88, in favourable
Figure 1 F2A sequences used for co-expression of fluorescent ‘reporter’ proteins. 2A mediates the co-translational ‘ribosome skipping’
event whilst fused to the upstream capsid protein 1D. Subsequently, 2A is co-translationally cleaved from 1D by an FMD virus proteinase (3Cpro)
which (artificially) defines the length of 2A: the functional entity is, however, longer than this 18aa tract. The 3Cpro cleavage is indicated by the
solid vertical arrow, the site of the 2A-mediated ribosome skipping event is shown by the open vertical arrow. Versions of various lengths were
used by producing truncations of the 58aa version.
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tiation’ in Figure 2b).
HeLa cells were transfected with this panel of con-
structs and cell lysates analysed 30 h post transfection.
Similarly, the two major cleavage products were detected
by western blotting either with an anti-GFP antibody
showing [GFP-F2A]s of decreasing size (Figure 2c, upper
blot), or, an anti-CherryFP antibody (Figure 2c, lower
blot). Uncleaved polyproteins were also detected, their
accumulation increasing as the length of F2A decreased,
being highest for the pGFP-F2A30-CherryFP construct.
These data, together with our in vitro analysis, demon-
strated that the cleavage efficiency is slightly reduced
when a shorter version (F2A30) is used, compared to that
observed for the 58aa version.
Fluorescence imaging was used to directly visualise co-
expression of fluorescent proteins. To demonstrate that
GFP and CherryFP proteins linked via F2A were co-
expressed within the same cell, we transfected HeLa
cells with the panel of pGFP-F2A-CherryFP constructs
(F2A58, F2A50, F2A40 and F2A30). In each case
transfected cells efficiently co-expressed both GFP and
CherryFP for up to 48 h post-transfection (Figure 2d;
the images presented for pGFP-F2A30-CherryFP were
representative of all constructs), with both proteins
localised to the cytoplasm of transfected cells (Figure 2e).
We could not detect any effect of increasing the length
of the C-terminal extension of GFP by F2A (30-58aa)
upon fluorescence.
In contrast to our constructs with F2A of 58–30 amino
acids, translation directed by plasmids pGFP-F2A20-
CherryFP and pGFP-F2A18-CherryFP showed three major
translation products (Figure 2b). In each gel track, the
most slowly migrating band corresponded to the un-
cleaved polyprotein forms [GFP-F2A20-CherryFP] and
[GFP-F2A18-CherryFP] of the expected molecular weights(~57 kDa). The bands corresponding to the two cleavage
products, [GFP-F2A20] or [GFP-F2A18] and CherryFP
could not be resolved due to the similar molecular
weights. In addition, three extra minor products were ob-
served in each of these translation reactions. Internal initi-
ation within the upstream GFP gene (probably Met88)
produced both the fastest migrating cleaved product, cor-
responding to protein of ~20 kDa which was almost un-
detectable on the gel (indicated in Figure 2b as ‘GFP
internal initiation’) and the second slow migrating
uncleaved product of ~50 kDa (highlighted with asterisk).
The third slower migrating minor product corresponded
to a protein of unknown identity (shown with white
arrow), although we suspect that this represents a transla-
tion product with a C-terminal adduct of tRNA.
Our in vivo studies were consistent with the in vitro
data: the western blotting data demonstrating that the
major products were the uncleaved [GFP-F2A20-Cherry
FP] and [GFP-F2A18-CherryFP] polyproteins (Figure 2c).
Small amounts of the CherryFP cleavage product, com-
pared to F2A58-30-based constructs, were still detectable
with anti-CherryFP antibody (Figure 2c, lower blot), the
upstream cleavage products were, however, either al-
most undetectable [GFP-F2A20] or absent [GFP-F2A18]
(Figure 2c, upper blot). It is important to note that the
amounts of proteins observed in these blots is a function
of detection using two quite different antibodies, raised
against either GFP or CherryFP and they have different af-
finities for their antigens. Interestingly, extracts of HeLa
cells transfected with plasmids pGFP-F2A20-CherryFP and
pGFP-F2A18-CherryFP also contained an unexpected pro-
tein with an estimated size of ~45 kDa (shown with white
arrow), similar to that detected in reticulocyte lysates,
which reacted with the anti-GFP, but not anti-CherryFP
antibodies. The nature of this protein, which could be
generated by a leaky scanning mechanism, or, be a product
Figure 2 Efficiency of F2A cleavage in GFP-F2A-CherryFP context. F2A sequences of various lengths were used to co-express GFP and
CherryFP proteins from pGFP-F2A-CherryFP constructs (a, schematic presentation) in vitro using TnT coupled transcription/ translation rabbit
reticulocyte lysates (b) and transfected HeLa cells (c). For TnT, reticulocyte lysates were programmed with 20 ng of plasmid DNA and translation
products were resolved by the 12% SDS-PAGE. For in vivo studies, HeLa cells were transfected with 1.5 μg of plasmid DNA and harvested 30 h
post transfection. Cells were lysed in RIPA buffer and equal amounts of total protein for each transfection were loaded onto 12% SDS-PAGE gel.
The proteins were transferred onto a nitrocellulose membrane, blocked in PBST containing 5% milk and probed with anti-GFP (upper blot) and
anti-CherryFP (lower blot) antibodies overnight at 4°C. Detection of bound primary antibody was achieved by using respective secondary
antibodies, followed by ECL detection. (d) Expression of fluorescent proteins was detected in transfected HeLa cells at 24 h and 48 h post
transfection in Evos microscope using 4 × objective. (e) Cellular co-localisation of [GFP-F2A] and CherryFP 30 h post-transfection. HeLa cells pre-
plated on cover slips were transfected with 0.5 μg of plasmid DNA and incubated for 30 h, fixed with 100% methanol and mounted using
VECTASHIELD mounting medium with DAPI. The images were acquired with Deltavision microscope using 100 × objective using Resolve 3D
software. All experiments were done in triplicates.
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investigation.
Interestingly, in the case of constructs which produced
a high level of cleavage, the fluorescent signals from
both GFP and CherryFP were distributed throughout the
cytoplasm, in the case of constructs which produced low
levels of cleavage, the fluorescent signals were accumu-
lated mostly around the nucleus (Figure 2e).
Tandem repeated cherry fluorescent proteins
To determine if the C-terminal region of the protein up-
stream of 2A affected the cleavage activity, we substitutedthe upstream gene (GFP) with that of CherryFP (Figure 3a).
Again, these sequences were linked by either F2A58, F2A50,
F2A40, F2A30, F2A20 or F2A18. Similar to our previous re-
sults, when reticulocyte lysates were programmed with
constructs encoding F2As of diminishing lengths, the
uncleaved polyprotein [CherryFP-F2A-CherryFP] formed a
very minor translation product for F2A of 58 to 30aa
(Figure 3b). In the case of these F2As, a doublet was ob-
served corresponding to the [CherryFP-F2A] cleavage
product. The fastest migrating product corresponded to the
cleavage product downstream of F2A, CherryFP. The trans-
lation profiles derived from all pCherryFP-F2A-CherryFP
Figure 3 Efficiency of F2A cleavage in CherryFP-F2A-CherryFP context. F2A sequences of various lengths were used to co-express two
CherryFP proteins from pCherryFP-F2A-CherryFP constructs (a, schematic presentation) in vitro using coupled transcription/ translation rabbit
reticulocyte lysates (b) and transfected HeLa cells (c). For TnT, reticulocyte lysates were programmed with 20 ng of plasmid DNA and translation
products were resolved by the 12% SDS-PAGE. For in vivo studies, HeLa cells were transfected with 1.5 μg of plasmid DNA and harvested 30 h
post transfection. Cells were lysed in RIPA buffer and equal amounts of total protein for each transfection were loaded onto 12% SDS-PAGE gel.
The proteins were transferred onto a nitrocellulose membrane, blocked in PBST containing 5% milk and probed with anti-CherryFP (upper blot)
and anti-FMDV2A (lower blot) antibodies overnight at 4°C. Detection of bound primary antibody was achieved by using respective secondary
antibodies, followed by ECL detection. All experiments were done in triplicates.
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produced minor translation products which corres-
ponded in size to products from internal initiation
at one of three start codons within the N-terminal
CherryFP sequence (Met10, Met17 and Met23, with
Met10 and Met23 being in more favourable Kozak con-
texts (AaCAUGG, ttCAUGc and caCAUGG, respect-
ively; upper-case letters indicate highly conserved bases,
and lower-case letters – bases that can vary). It should
be noted that internal initiation at Met10 produces the
same decrease in molecular mass as that observed when
the length of 2A was designed in 10aa increments.
These observations in vitro were confirmed by our
in vivo experiments. Cells were transfected with the panel
of pCherryFP-F2A-CherryFP constructs and cleavage activ-
ities determined by western blotting (Figure 3c). As with
the pGFP-F2A-CherryFP constructs, uncleaved [CherryFP-
F2A58, 50, 40-CherryFP] polyproteins were barely detectable
by the anti-CherryFP antibodies. The major products in
these cases were the [CherryFP-F2A] and CherryFP cleav-
age products. Again, [CherryFP-F2A] migrated as a doub-
let, with the fastest migrating product corresponding to the
CherryFP cleavage product - of uniform size across the gel
tracks (Figure 3c, upper blot). Although easily detectable
for the 30aa version, the uncleaved form accumulated to
a somewhat lesser degree than the two major cleavageproducts. As we observed for the in vitro translations, the
upstream cleavage products (now [CherryFP-F2A]) were
detected by an anti-FMDV2A antibody (Figure 3c, lower
blot), but the uncleaved [CherryFP-F2A-CherryFP] was
not. Using this antibody, two non-specific proteins were
detected both in transfected and mock-transfected cells
(Figure 3c, lower blot, highlighted with asterisks). Interest-
ingly, the amounts of the upstream and downstream cleav-
age products detected by both anti-CherryFP and anti-
FMDV2A antibodies in HeLa cells transfected with
pCherryFP-F2A58-CherryFP construct were lower than
those expressed from constructs with shorter 2As.
Similar to our data obtained for pGFP-F2A20-CherryFP
and pGFP-F2A18-CherryFP, both in reticulocyte lysates
(Figure 3b) and in transfected HeLa cells (Figure 3c), the
uncleaved polyproteins [CherryFP-F2A20-CherryFP] and
[CherryFP-F2A18-CherryFP] represented the major trans-
lation products. The cleavage products upstream of F2A
([CherryFP-F2A20] and [CherryFP-F2A18]) migrated as
doublets, as discussed above. The cleavage product down-
stream of F2A, CherryFP, was of uniform size across all
the gel tracks. Interestingly, it appeared that cleavage was
more efficient when CherryFP was upstream of 2A, rather
than GFP – shown using both anti-CherryFP (Figure 3c,
upper blot) and anti-FMDV2A antibodies (Figure 3c,
lower blot). We assume the higher amounts of cleaved
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quences of the upstream gene (CherryFP versus GFP), as
the linker sequences connecting them to F2A were identi-
cal in all constructs (−RAKRSLE-). In addition, similar to
the data presented for pGFP-F2A-CherryFP constructs,
two extra bands were observed in both reticulocyte lysates
and HeLa cells transfected with constructs containing
F2As of 20 and 18 amino acids. The slow migrating
band corresponded to protein produced by internal ini-
tiation within the upstream Cherry gene (probably Met71;
Figure 3b, highlighted with asterisk). This product was
also detected in HeLa cells using anti-CherryFP anti-
bodies (Figure 3c, upper blot, highlighted with asterisk).
The extra doublet (~45 kDa) we observed using reticu-
locyte lysates (Figure 3b, shown with white arrow) was
also detected in HeLa cell extracts using anti-CherryFP
antibodies (Figure 3c, upper blot, shown with white arrow),
but not anti-FMDV 2A antibodies.
Co-expression of CherryFP and GFP fluorescent proteins
from pCherryFP-F2A-GFP constructs
The downstream CherryFP sequences were replaced
with GFP to create pCherryFP-F2A-GFP, again linked
with the different lengths of F2A (Figure 4a). The pat-
tern of accumulation of uncleaved polyproteins was asFigure 4 Efficiency of F2A cleavage in CherryFP-F2A-GFP context. F2A
GFP proteins from pCherryFP-F2A-GFP constructs (a, schematic presentatio
lysates (b) and transfected HeLa cells (c). For TnT, reticulocyte lysates were
were resolved by the 12% SDS-PAGE. For in vivo studies, HeLa cells were tr
transfection. Cells were lysed in RIPA buffer and equal amounts of total pro
proteins were transferred onto a nitrocellulose membrane, blocked in PBST
CherryFP (lower blot) antibodies overnight at 4°C. Detection of bound prim
followed by ECL detection. All experiments were done in triplicates.observed before: an increase as the length of F2A
decreases. The uncleaved polyprotein formed the
major product in the case of pCherryFP-F2A20-GFP
and pCherryFP-F2A18-GFP both in reticulocyte lysates
(Figure 4b) and in HeLa cells (Figure 4c). The cleaved up-
stream proteins, [CherryFP-F2A]s, expressed from all six
constructs, migrated as a doublet in the case of transla-
tion in vitro (Figure 4b) and in vivo - in the latter case
detected by western blotting using anti-CherryFP anti-
bodies (Figure 4c, lower blot). The second major band
corresponded to the downstream cleavage product, GFP
(Figure 4b and 4c, upper blot). Translation profiles derived
from pCherryFP-F2A-GFP constructs with F2As58-30
showed a certain level of internal initiation (probably from
Met71) within the upstream CherryFP gene. This pro-
duced fast migrating bands corresponding to cleaved
products of decreasing molecular weights (Figure 4b, in-
dicated as ‘CherryFP internal initiation’).
The F2A20 and F2A18 versions showed poor cleavage:
the GFP cleavage product was almost undetectable in
western blots using the anti-GFP antibody (Figure 4c,
upper blot). Internal initiation was observed in the reticu-
locyte lysate translation in vitro. The faster migrating
bands corresponded to N-terminally truncated [CherryFP-
F2A] proteins (probably produced by initiation at Met71;sequences of various lengths were used to co-express CherryFP and
n) in vitro using coupled transcription/ translation rabbit reticulocyte
programmed with 20 ng of plasmid DNA and translation products
ansfected with 1.5 μg of plasmid DNA and harvested 30 h post
tein for each transfection were loaded onto 12% SDS-PAGE gel. The
containing 5% milk and probed with anti-GFP (upper blot) and anti-
ary antibody was achieved by using respective secondary antibodies,
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ation at this site also accounts for products migrating
somewhat more rapidly than the full-length (uncleaved)
polyprotein (Figure 4, b and c, highlighted with asterisks).
This extra product was observed in both reticulocyte ly-
sates programmed with the plasmids encoding F2As of 20
and 18aa, and in extracts of HeLa cell transfected with
these constructs. In these cases, the poor cleavage activity
leads to an accumulation of uncleaved products and
enabled sufficient material to accumulate to be observed
directly (translation in vitro), or, be recognised by both
anti-CherryFP and anti-GFP antibodies.
‘Fine-tuning’ of shorter F2A sequences
To assess the utility of shorter F2A sequences for co-
expression, we produced a series of constructs in which
sequences encoding GFP and CherryFP ‘reporter’ pro-
teins were linked by the panel of N-terminally single-
residue truncated versions of F2A (F2As25-21; Figure 1).
These constructs were analysed together with the previ-
ously described pGFP-F2A-CherryFP constructs contai-
ning F2A58, F2A30, F2A20 and F2A18. Based upon the
data shown in Figure 2, pGFP-F2A58-CherryFP / pGFP-
F2A30-CherryFP were used as exemplars of highly effi-
cient 2A cleavage and pGFP-F2A20-CherryFP / pGFP-
F2A18-CherryFP as exemplars of inefficient cleavage.
Analysis of the translation products showed three major
bands which corresponded to the three predicted translationFigure 5 ‘Fine-tuning’ of F2A cleavage in GFP-F2A-CherryFP context.
CherryFP proteins from pGFP-F2A-CherryFP constructs (a, schematic presen
reticulocyte lysates (b) and transfected HeLa cells (c). For TnT, reticulocyte
products were resolved by the 12% SDS-PAGE. For in vivo studies, HeLa cel
post transfection. Cells were lysed in RIPA buffer and equal amounts of tot
The proteins were transferred onto a nitrocellulose membrane, blocked in
anti-CherryFP (lower blot) antibodies overnight at 4°C. Detection of bound
antibodies, followed by ECL detection. All experiments were done in triplicproducts and their molecular weights: uncleaved [GFP-
F2A-CherryFP] polyprotein and the two major cleavage
products, [GFP-F2A] and CherryFP (Figure 5b). While
the intensities of the latter bands were much higher in
reticulocyte lysates programmed with constructs con-
taining F2As of 30, 25, 24 and 23aa (in comparison with
F2As of 22-18aa), the translation products derived from
the four constructs encoding shorter 2A sequences were
mostly uncleaved. Translation profiles derived from all
constructs showed a low level of internal initiation
(probably from Met88) within the upstream GFP gene.
The fast migrating band corresponded to N-terminally
truncated cleaved products [GFP-F2A] and slow mig-
rating band corresponded to N-terminally truncated
uncleaved polyprotein (Figure 5b, highlighted with
asterisk). Again, the additional translation product of ~
45KDa was observed (more prominent with F2A ver-
sions of 25aa and shorter), but was absent in constructs
with F2A30 and F2A58. This additional translation prod-
uct was detected by anti-GFP (Figure 5c, upper blot,
shown with white arrow), but not anti-CherryFP anti-
bodies (Figure 5c, lower blot). From F2A25, the intensity
of this band increased as the length of F2A decreased.
In the cases of F2A of 23aa and longer, the translation
products upstream of F2A ([GFP-F2A]) and down-
stream ([CherryFP]) were easily detected by anti-GFP
(Figure 5c, upper blot) and anti-CherryFP antibodies
(Figure 5c, lower blot), respectively. In the case ofF2A sequences of various lengths were used to co-express GFP and
tation) in vitro using coupled transcription/ translation rabbit
lysates were programmed with 20 ng of plasmid DNA and translation
ls were transfected with 1.5 μg of plasmid DNA and harvested 30 h
al protein for each transfection were loaded onto 12% SDS-PAGE gel.
PBST containing 5% milk and probed with anti-GFP (upper blot) and
primary antibody was achieved by using respective secondary
ates.
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whilst for F2A18 no cleavage products could be detected.
Discussion
Initial characterization of the FMDV 2A region by Ryan et
al. [10] showed that while the FMDV 2A/2B cleavage ac-
tivity was mediated by residues located within the 19
amino acid version of F2A, N-terminal truncation of F2A
reduced cleavage efficiency. Ryan and Drew [14] further
described the construction of plasmid (pCAT2AGUS) in
which a 19 amino acid version of F2A was inserted be-
tween the reporter genes chloramphenicol acetyl trans-
ferase (CAT) and β-glucuronidase (GUS). Analyses of
in vitro translation products derived from a series of
constructs in which sequences were progressively de-
leted from the N-terminal region of F2A showed that
activity was ablated in versions with less than 13 resi-
dues (−LKLAGDVESNPGP-). It was concluded that
residues comprising the N-terminal portion of the F2A
region ‘whilst being influential were not critical for
cleavage activity’ [14].
According to the model for 2A-mediated cleavage, resi-
dues that may influence the activity are predicted to reside
within the exit tunnel of the ribosome. The use of longer
versions of F2A with N-terminal extensions derived from
capsid protein 1D (to a total of ~30aa) were reported to
produce higher levels of cleavage [10-13]. Specifically, in a
series of constructs based upon pGFP2AGUS, N-terminal
extension of 2A by 5aa of 1D (equivalent to F2A25) im-
proved cleavage, but extension by 14, 21 and 39aa (equiva-
lent of F2A of 35, 40 and 58aa) produced complete
cleavage and an equal stoichiometry of both translation
products in vitro [11].
These observations are consistent with our in vitro and
in vivo data on cleavage efficiency in constructs expressing
GFP and CherryFP fluorescent ‘reporter’ proteins sepa-
rated by F2As of 58, 50, 40 and 30aa. For all constructs
tested, the in vitro analyses showed the polyprotein was ef-
ficiently cleaved, the upstream protein bearing the F2A
‘tail’ at its C-terminus. In transfected HeLa cells, however,
small amounts of uncleaved polyprotein were detected by
western blotting (using anti-GFP / anti-CherryFP, but not
anti-FMDV2A, antibodies) in constructs encoding the
F2A30 version. Swapping the gene order had no effect on
cleavage efficiency when longer versions of 2As were used,
showing that for these particular lengths, cleavage is not
sensitive to the C- terminal sequence of the upstream pro-
tein - since this has already transited through the exit tun-
nel of the ribosome.
Further experiments demonstrated that the cleavage
efficiency was gradually reduced with each N-terminal
amino acid deletion, shown by both our in vitro and
in vivo data when pGFP-F2A-CherryFP constructs with
F2As of 25aa to 18aa were used. The length of F2A of23aa was demonstrated to be the most efficient of the
shorter versions of 2A, and deletion of just one amino
acid from its N-terminus resulted in a substantial de-
crease in cleavage efficiency, whereas truncation to
F2A18 essentially ablated cleavage: data apparently at
variance with those previously reported for F2A20, where
cleavage was efficient [10, 11; discussed below]. Cleavage
efficiency was improved somewhat in constructs where
the upstream gene was CherryFP (rather than GFP).
The exit tunnel of the ribosome accommodates 30–40
amino acids. For FMDV, the C-terminal region of pro-
tein 1D (immediately upstream of 2A) must have evo-
lved to interact with the exit tunnel such that F2A (18aa
long) mediates cleavage highly efficiently. In the case of
artificial polyproteins, the ‘authentic’ upstream context
of 2A is replaced with foreign gene or linker sequences
which may create an unfavourable environment for ribo-
some ‘skipping’: their presence inside the exit tunnel
may adversely affect the interaction of F2A with the
ribosome. Low cleavage efficiency may arise, therefore,
due to (i) the nature of the C-terminal region of the up-
stream gene, or, (ii) the manner in which it is linked to
the shorter versions of F2A.
The data presented here is in agreement with many pre-
viously published studies that successfully used F2A and
‘2A-like’ sequences in a wide range of heterologous sys-
tems, notably, adoptive cell cancer gene therapies, genetic
engineering of human stem cells and the co-expression of
transcription factors for the induction of pluripotent stem
cells [11,19,20,22-25,29-35]. Our findings also help explain
previously published studies in which incomplete cleavage
was observed. To avoid using longer 2A sequences (which
remain attached at the C-terminus of the upstream pro-
tein), researchers used shorter versions of F2A. Conflicting
cleavage efficiencies have been reported for 2As of the
same lengths [11,14,19,22,25,27]. For example, Furler et al.
[18] showed that within the context of a poliovirus vector,
2A-mediated cleavage was incomplete when F2A24 was
used. Fang et al. [19] described similar results for the con-
stitutive expression of full-length two-chain antibodies
from a single ORF by linking the heavy and light antibody
chains with F2A24. Different cleavage efficiencies depend-
ing on protein arrangement were observed when GFP,
EGFP and hrGFP were co-expressed with cytochrome
P450 2B1 (CYP2B1) via F2A20 [36]. In addition, Donnelly
and co-workers, using F2A20 in GFP2AGUS and GUS2-
AGFP, also reported the presence of small amounts of
uncleaved polyprotein [11]. With F2A19, cleavage was
reported to be less efficient (70%) in [CFP-2A-PAC] con-
text, with some uncleaved polyprotein still present [37],
while de Felipe and co-workers [17] used an F2A18 version
in the generation of retroviral vectors and also observed
uncleaved polyprotein. The cleavage was, however, repor-
ted to be complete when the sequence was extended to
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GUS and CAT proteins in different arrangements and
demonstrated that [GUS-2A-CAT] and [GUS-2A-GUS]
were cleaved to completion, while [CAT-2A-GUS] was
not [38].
Interestingly, we show here that pGFP-F2A20-CherryFP
and pGFP-F2A18-CherryFP produced poor cleavage both
in vitro and in vivo, apparently at variance with our own
previously published data [10,11]. In these studies, the
pGFP2AGUS construct contained the same upstream
GFP gene and the same F2A20 sequence and produced ef-
ficient cleavage. Sequence comparison of pGFP-F2A20-
CherryFP and pGFP2AGUS constructs shows that the dif-
ferences are only observed in the sequence immediately
upstream of 2A (RAKRSLE vs SGSRGAC, respectively).
Ironically, this seven amino acid stretch is a part of neither
F2A nor C terminus of the upstream GFP, but is actually
composed of two different restriction sites introduced for
cloning purposes during the construction of both plas-
mids. The effect of the differences in this particular region
on the efficiency of 2A-mediated cleavage is the subject of
a separate report [39].
Swapping the order of fluorescent ‘reporter’ proteins
in our expression systems had no effect on the general
pattern of cleavage efficiency. However, while two genes
could be effectively co-expressed (irrespective of pos-
ition) when linked by a longer version of F2A (30aa and
longer), we did observe a small effect for the shorter
F2A20 and F2A18 versions.
Conclusions
In summary, F2As are used widely in biotechnology and
biomedicine and we wished to identify the source(s) of ap-
parent discrepancies in the literature with regards to cleav-
age efficiency. While constructs containing F2A of 58-
23aa in length exhibited enhanced abilities for cleavage
compared to the constructs with F2A of 22aa and shorter,
with least efficient 2As being those of 20aa and 18aa, we
suggest that researchers use F2A30 if opting for a shorter
sequence. This 2A proved to be most optimal in terms of
both length and cleavage efficiency, and, in our hands, was
unaffected by the sequence of the upstream gene. A more
extensive characterization of sequence requirements be-
tween the C-terminal region of the upstream protein and
the N-terminal part of F2A is underway to test the specu-
lation that this particularly interesting region of the se-
quence may have certain effect on 2A-mediated cleavage.
Ultimately, the fine-tuning of the F2A sequence can help
researchers in their efforts to efficiently co-express various
multiple proteins for successful biomedical strategies.
Methods
The following reagents were obtained from commercial
suppliers: Pfu polymerase, T4 DNA ligase, restrictionenzymes, JM109 competent cells, Quick TnT rabbit re-
ticulocyte lysate kit (Promega, Madison, WI, USA); S35
methionine (MP Biomedicals, Santa Ana, CA, USA);
EDTA-free protease inhibitor cocktail (Sigma-Aldrich
Company Ltd, Dorset, UK); pcDNA3.1, anti-RFP, rabbit
purified polyclonal antibody against Red Fluorescent
Protein (1:1000 dilution), anti-GFP, mAb 3E6, anti-
Green Fluorescent Protein, mouse monoclonal antibody
(1:1000 dilution), anti-β-tubulin, mouse monoclonal
antibody (1:2000 dilution), Lipofectamine2000 transfec-
tion reagent, iBlot Gel Transfer Stacks, nitrocellulose
(Life Technologies Ltd, Paisley, UK); secondary HRP-
conjugated polyclonal goat anti-mouse and anti-rabbit
antibodies (Dako UK Ltd, Ely, UK); rabbit anti-FMDV
2A antiserum raised against the synthetic peptide NH2-
LLNFDLLKLAGDVESNPGP-COOH; EZ-ECL Chemilu-
minescence Detection Kit for HRP (Geneflow Ltd,
Elmhurst, UK); VECTASHIELD mounting medium with
DAPI (VECTOR Laboratories Ltd, Peterborough, UK);
Oligonucleotides were purchased from Integrated DNA
Technologies (Coralville, Iowa, USA).
Construction of plasmids
pGFP-F2As-CherryFP constructs (F2As of 58, 50, 40, 30,
25–20, and 18aa, sequences shown in Figure 1). To make
pGFP-F2A58-CherryFP construct, F2A58 sequence, obtained
by digesting pSV7 plasmid (kindly provided by Sandra
Varte) with NsiI and ApaI restriction enzymes, was cloned
into pJC3 plasmid (pcDNA3.1-based with T2A linking GFP
and CherryFP genes) in place of T2A sequence using these
restriction sites. pGFP-F2A58-CherryFP construct was then
used as a template to produce deletions of F2A. Forward
oligonucleotides incorporating XhoI restriction site: (5′-
CTCGAGAAGAGGGCCGAAACATACTGTCCAAGG-3′
for F2A50, 5′-CTCGAGTTGCTGGCAATCCACCCAAC
TGAAGCC-3′ for F2A40, 5′-GCGCTCGAGCACAAAC
AGAAAATTGTGGCACCGGTG-3′ for F2A30, 5′-GCG
CTCGAGGTGGCACCGGTGAAACAGACTTTG-3′ for
F2A25, 5′-GCGCTCGAGGCACCGGTGAAACAGACTTT
G-3′ for F2A24, 5′-GCGCTCGAGCCGGTGAAACAGAC
TTTGAATTTTG-3′ for F2A23, 5′-GCGCTCGAGGTGA
AACAGACTTTGAATTTTGAC-3′ for F2A22, 5′-GCGC
TCGAGAAACAGACTTTGAATTTTGACCTTC-3′ for
F2A21, 5′-GCGCTCGAGCAGACTTTGAATTTTGACC
TTCTCAAG-3′ for F2A20, 5′-GCGCTCGAGTTGAATT
TTGACCTTCTCAAGTTGGCG-3′ for F2A18) and a re-
verse oligonucleotide incorporating NotI restriction site (5′-
TAGAAGGCACAGTCGAGGC-3′) were used to amplify
F2As-CherryFP with 2As of various lengths. The PCR pro-
ducts were digested with XhoI and NotI restriction enzymes
and cloned into pGFP-F2A58-CherryFP in place of F2A58-
CherryFP sequence using XhoI and NotI restriction sites.
pCherryFP-F2As-CherryFP constructs (F2As of 58, 50,
40, 30, 20, and 18aa). Respective pGFP-F2As-CherryFP
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enzymes to substitute GFP sequence with that of
CherryFP. In order to do that, pJC3 plasmid was used as a
template to amplify CherryFP gene using forward (5′-
GCGGGATCCATGGTGAGCAAGGGCGAGGAGGATA
AC -3′) and reverse (5′-GCGATGCATTTTGTACAAT
TCATCCATGCCGCCG -3′) primers incorporating, re-
spectively, BamHI and NsiI restriction sites. PCR products
were digested with BamHI and NsiI restriction enzymes
and ligated into prepared vectors.
pCherryFP-F2As-GFP constructs (F2As of 58, 50, 40,
30, 20 and 18aa). Respective pCherryFP-F2As-CherryFP
constructs were digested with ApaI and EcoRI restric-
tion enzymes to substitute downstream CherryFP gene
with that of GFP. pJC3 plasmid was used as a template
to amplify GFP gene using forward (5′-GCGGGGCCC
GATATCGTGTCCAAAGGGGAAGAG-3′) and reverse
(5′-GCGGAATTCTTACTTATACAGCTCGTCCATGC
CGAG-3′) primers incorporating ApaI and EcoRI re-
striction sites. PCR products were digested with ApaI
and EcoRI restriction enzymes and ligated into pre-
pared vectors.
Transcription and translation
Plasmid constructs were used to programme Quick TnT
Coupled Transcription/ Translation reticulocyte lysate
systems (Promega) and the reactions repeated three times.
Translation reactions (10 μl) were performed according to
the manufacturer’s instructions. Briefly, 20 ng of plasmid
DNA was used to programme rabbit reticulocyte lysates
containing 35S methionine (10 μCi) and the reactions were
incubated at 30°C for 1 h. Translation reactions were
stopped by the addition of 2x protein dissociation buffer.
Protein products were analysed by 12% SDS-PAGE. Con-
trols of TnT reactions programmed with ‘empty’ vectors
produced no translation products (data not shown).
Expression in HeLa cells
HeLa cells were maintained in DMEM medium supple-
mented with 10% FCS. For western blotting, the cells were
transfected in 60 mm dishes (pre-plated 20 h earlier to
60% confluency) with 1.5 μg of plasmid DNA and 7 μl of
Lipofectamine2000 (Invitrogen) in a final volume of
400 μl OptiMEM. Transfection mix was added to 4 ml of
antibiotic-free serum-containing medium and cells were
incubated for a total of 30 h post-transfection. All trans-
fections were performed in triplicate. Controls with
‘empty’ expression vector transfected cells produced no
translation products (western blotting) or fluorescence
(data not shown).
Western blotting
30 h post-transfection, cells were washed twice with 1 ml
of PBS and harvested in 1 ml of PBS by centrifugation at2000 rpm for 5 min. Whole-cell lysates were prepared in
70 μl of radioimmuno precipitation assay buffer, RIPA
(150 mM NaCl, 10 mM Tris pH 7.4, 1% Triton X-100, 1%
Na deoxycholate, 0.1% SDS, and freshly added 1/20 vo-
lume of EDTA-free protease inhibitor cocktail) by incuba-
tion on ice for 30 min and centrifugation at 12000 rpm
for 20 min at 4°C. Cellular debris was discarded and
supernatants containing proteins were analysed by 12%
SDS-PAGE. The proteins were then transferred to a
nitrocellulose membrane, which was probed with anti-
GFP, anti-CherryFP or anti-FMDV 2A primary antibodies
overnight after blocking in PBST containing 5% milk for
1 h. Following overnight incubation, the membranes were
washed three times in PBST. Detection of bound primary
antibodies was performed with respective HRP-secondary
antibodies (Dako) in PBST containing 5% milk for 1 h, the
membranes were washed three times with PBST, rinsed in
deionised water and subjected to enhanced chemilumi-
nescence by incubating it in freshly-prepared visualisation
solution for 2 min. Membrane was exposed to an auto-
radiograph film for 3 to 45 seconds.
Fluorescence microscopy
Transfection of HeLa cells was performed as described
above for western blotting, however, 0.5 μg of plasmid
DNA and 5 μl of Lipofectamine2000 in a final volume of
200 μl OptiMEM were added to 2 ml of media in each
well of a 6-well plate containing coverslips. 30 h post-
transfection the cells were washed twice with 1 ml of PBS,
fixed with 1 ml of ice-cold 100% methanol for 10 min and
washed again with 1 ml of PBS. The coverslips were moun-
ted in VECTASHIELD (an antifade mounting medium,
VECTOR Laboratories). The images were acquired with
Deltavision microscope using 100 × objective using Resolve
3D software. Experiments were done in triplicates.
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